GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

BioLargo BLGO · USD

Materials · US listing · 🇺🇸 United States

Compare

0.07

-2.10%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About BioLargo

From its filings with the US Securities and Exchange Commission

SEC filings

BioLargo is based in Westminster, California and is incorporated in Delaware. Its shares trade on OTC under the ticker BLGO. The SEC classifies its business as chemicals & allied products. In the fiscal year to 31 December 2025, it reported revenue of $7.8m and a net loss of $15.2m. At that date it held total assets of $8.3m and shareholders' equity of $4.0m.

Read the filing on SEC.gov ↗

Company facts

Sector
Materials
Industry
Chemicals
Listed since
12 Dec 1991
Employees
44
Head office
14921 CHESTNUT ST., WESTMINSTER, CA, 92683
Incorporated in
DE
Classification
Chemicals & Allied Products
Filer status
Non-accelerated filer<br>Smaller reporting company

Leadership

Pay as last reported

  • Mr. Dennis CalvertChairman of the Board, President, Chief Executive Officer, since 2002$317,952
  • Mr. Charles DarganChief Financial Officer$233,850
  • Mr. Joseph ProvenzanoExecutive Vice President - Operations, Corporate Secretary, Director, since 2002$261,451
  • Mr. Kenneth CodeChief Scientific Officer, Director, since 2007$301,203
  • Ms. Christina BrayIndependent Director$51,273
  • Mr. Dennis MarshallIndependent Director$148,541
  • Ms. Linda ParkIndependent Director$51,273
  • Mr. Jack StrommenIndependent Director$42,442

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • BioLargo Inc has several strengths that contribute to its competitiveness and growth potential. These include:

Weaknesses

  • Despite its strengths, BioLargo Inc also faces certain weaknesses that may pose challenges or limitations:

Opportunities

  • BioLargo Inc can leverage various opportunities to drive its future growth and expansion:

Threats

  • BioLargo Inc faces certain threats that could hinder its growth and success in the market:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.